DK1025121T3 - Peptider, som er i stand til at hæmme interaktionen mellem preseniliner og peptidet beta-amyloid eller dets precursor - Google Patents

Peptider, som er i stand til at hæmme interaktionen mellem preseniliner og peptidet beta-amyloid eller dets precursor

Info

Publication number
DK1025121T3
DK1025121T3 DK98951547.3T DK98951547T DK1025121T3 DK 1025121 T3 DK1025121 T3 DK 1025121T3 DK 98951547 T DK98951547 T DK 98951547T DK 1025121 T3 DK1025121 T3 DK 1025121T3
Authority
DK
Denmark
Prior art keywords
beta
interaction
app
iii
amino acids
Prior art date
Application number
DK98951547.3T
Other languages
Danish (da)
English (en)
Inventor
Christian Czech
Soline Reboul-Becquart
Luc Mercken
Laurent Pradier
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Priority claimed from PCT/FR1998/002278 external-priority patent/WO1999021886A1/fr
Application granted granted Critical
Publication of DK1025121T3 publication Critical patent/DK1025121T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
DK98951547.3T 1997-10-24 1998-10-23 Peptider, som er i stand til at hæmme interaktionen mellem preseniliner og peptidet beta-amyloid eller dets precursor DK1025121T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9713384A FR2770217B1 (fr) 1997-10-24 1997-10-24 Peptides capables d'inhiber l'interaction entre les presenilines et le precurseur du peptide b-amyloide et/ou le peptide b-amyloide
US9567198P 1998-08-07 1998-08-07
PCT/FR1998/002278 WO1999021886A1 (fr) 1997-10-24 1998-10-23 PEPTIDES CAPABLES D'INHIBER L'INTERACTION ENTRE LES PRESENILINES ET LE PEPTIDE β-AMYLOIDE OU SON PRECURSEUR

Publications (1)

Publication Number Publication Date
DK1025121T3 true DK1025121T3 (da) 2011-11-28

Family

ID=9512632

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98951547.3T DK1025121T3 (da) 1997-10-24 1998-10-23 Peptider, som er i stand til at hæmme interaktionen mellem preseniliner og peptidet beta-amyloid eller dets precursor

Country Status (8)

Country Link
AT (1) ATE521630T1 (es)
DK (1) DK1025121T3 (es)
ES (1) ES2372586T3 (es)
FR (1) FR2770217B1 (es)
PL (1) PL198079B1 (es)
PT (1) PT1025121E (es)
SI (1) SI1025121T1 (es)
ZA (1) ZA989745B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6815175B2 (en) 2001-03-16 2004-11-09 Cornell Research Foundation, Inc. Anti-amyloid peptide antibody based diagnosis and treatment of a neurological disease or disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013069A1 (en) * 1991-01-21 1992-08-06 Imperial College Of Science, Technology & Medicine Test and model for alzheimer's disease
US5986054A (en) * 1995-04-28 1999-11-16 The Hospital For Sick Children, Hsc Research And Development Limited Partnership Genetic sequences and proteins related to alzheimer's disease
AU732508B2 (en) * 1996-01-26 2001-04-26 Governing Council Of The University Of Toronto, The Nucleic acids and proteins related to Alzheimer's disease, and uses therefor

Also Published As

Publication number Publication date
FR2770217A1 (fr) 1999-04-30
PT1025121E (pt) 2011-11-04
ATE521630T1 (de) 2011-09-15
ES2372586T3 (es) 2012-01-24
FR2770217B1 (fr) 2001-12-07
SI1025121T1 (sl) 2011-12-30
PL198079B1 (pl) 2008-05-30
ZA989745B (en) 1999-05-04
PL340054A1 (en) 2001-01-15

Similar Documents

Publication Publication Date Title
McKeehan et al. Purification and partial characterization of the aminoacyl transfer ribonucleic acid binding enzyme from rabbit reticulocytes
Anderson et al. Characterization of the adenovirus 2 virion protein, mu
Laver Structural studies on the protein subunits from three strains of influenza virus
Stevens et al. Comparison of calcium-binding proteins. Bovine heart and brain protein activators of cyclic nucleotide phosphodiesterase and rabbit skeletal muscle troponin C.
Suchanek et al. Translation of melittin messenger RNA in vitro yields a product terminating with glutaminylglycine rather than with glutaminamide.
Noro et al. Isolation and characterization of a third proteoglycan (PG-Lt) from chick embryo cartilage which contains disulfide-bonded collagenous polypeptide.
Deibler et al. Chromatographic fractionation of myelin basic protein: Partial characterization and methylarginine contents of the multiple forms
Hendrix et al. Protein fusion: a novel reaction in bacteriophage λ head assembly
Bromer et al. Amino acid sequence of bovine glucagon
McDonald et al. Mitochondrial proteomics: Undercover in the lipid bilayer
ATE178652T1 (de) Verbessertes verfahren zur herstellung von endotoxinbindungsproteinen
NO175004C (no) Fremgangsmåte til isolering av basiske insuliner fra proteinblandinger som inneholder slike basiske insuliner
Fortis et al. A new approach for the detection and identification of protein impurities using combinatorial solid phase ligand libraries
Kreil Biosynthesis of Melittin, a Toxic Peptide from Bee Venom: Amino‐Acid Sequence of the Precursor
ATE208816T1 (de) Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5
Champion et al. A two‐dimensional protein map of Chinese hamster ovary cells
Rider et al. An agarose‐based gel‐concentration system for microsequence and mass spectrometric characterization of proteins previously purified in polyacrylamide gels starting at low picomole levels
WO1999025878A3 (en) Methods for modulating and identifying cellular senescence
Castro‐Borges et al. The 20S proteasome of Schistosoma mansoni: a proteomic analysis
MXPA94006367A (es) Gene novedoso.
Luduena et al. Characterization of KB cell alkaline phosphatase. Evidence of similarity to placental alkaline phosphatase.
Hjorth et al. Multiple structural genes for mouse amylase
Zanders et al. Separation and characterization of a protein antigen from cells of Streptococcus mutans
Walker et al. The Subunits of Rabbit‐Muscle Phosphofructokinase: A Search for Sequence Repetition
DK1025121T3 (da) Peptider, som er i stand til at hæmme interaktionen mellem preseniliner og peptidet beta-amyloid eller dets precursor